1.北京中医药大学,北京市朝阳区北三环东路11号,100029
2.中国中医科学院广安门医院
3.遵义医科大学第三附属医院
4.陕西中医药大学第二附属医院
5.中日友好医院
6.甘肃中医药大学
tongxiaolin@vip.163.com
收稿:2022-12-20,
修回:2023-03-16,
纸质出版:2023-05-02
移动端阅览
丁齐又,赵林华,宋斌等.两个重构——中医药传承创新发展的重要路径[J].中医杂志,2023,64(09):865-869.
DING Qiyou,ZHAO Linhua,SONG Bin,et al.Two Reconstructions:An Important Path for the Preservation and Innovative Development of Traditional Chinese Medicine[J].Journal of Traditional Chinese Medicine,2023,64(09):865-869.
丁齐又,赵林华,宋斌等.两个重构——中医药传承创新发展的重要路径[J].中医杂志,2023,64(09):865-869. DOI: 10.13288/j.11-2166/r.2023.09.001.
DING Qiyou,ZHAO Linhua,SONG Bin,et al.Two Reconstructions:An Important Path for the Preservation and Innovative Development of Traditional Chinese Medicine[J].Journal of Traditional Chinese Medicine,2023,64(09):865-869. DOI: 10.13288/j.11-2166/r.2023.09.001.
以中医药学为主体,融合现代医学研究成果与技术方法,创新中医药临床诊疗模式,丰富中医药理论体系,是现阶段中医药创新发展的一大重要方向。然而现代医学背景下的中医药传承创新工作还存在中医传统辨治模式与现代疾病临床诊疗难以有机融合、中医宏观辨治思路与现代医学微观理化指标不能精准对接两个关键问题需要解决,据此提出“两个重构”(即重构现代中医诊疗体系与重构现代中医本草体系)理论框架并对其内涵、目的、方法及意义进行系统阐释。认为通过借鉴现代医学疾病认知,继承传统中医审病思维,对现代疾病进行中医分类分期分证,进而可实现现代中医诊疗体系的重构;同时通过吸纳现代药理研究成果,融汇中药传统功效认识,构建方药量效理论框架推动现代中医本草体系的重构。“两个重构”的实现可在继承并发扬中医调态优势的前提下,突破传统辨证论治局限性,提高中医对现代疾病临床诊疗的精准性,是推动中医药传承创新发展的重要路径。
Taking traditional Chinese medicine (TCM) as the main body, integrating modern medical research results and technology methods, innovating clinical diagnosis and treatment mode, and enriching the theoretical system are important directions for the innovative development of TCM at present. However, there are still two key problems to be solved in the process of innovative development of TCM under the background of modern medicine. On the one hand, the traditional syndrome differentiation and treatment mode of TCM is difficult to integrate with modern cli-nical diagnosis and treatment of diseases; on the other hand, the macro syndrome differentiation and treatment in TCM cannot accurately dock with the microscopic physical and chemical indicators of modern medicine. Therefore, in this paper, we innovatively put forward the theoretical framework of “two reconstructions”,i.e. reconstruction of diagnostic and treatment system and materia medica system in modern Chinese medicine, and systematically explain its connotation, purpose, method and significance. We advocate that by learning from the cognition of modern medicine diseases, inheriting the disease examination thinking of TCM, and classifying and staging modern diseases in the way of TCM, the modern TCM diagnosis and treatment system can be reconstructed. At the same time, we also advocate that by absorbing the results of modern pharmacological research, integrating the understanding of the efficacy of Chinese material medica, and constructing the theoretical framework of dose-response relationship in TCM prescription, the reconstruction of modern Chinese herbal medicine system can be completed. On the premise of inheriting and carrying forward the advantages of TCM, the realization of “two reconstruction” can break through the limitations of traditional treatment based on syndrome differentiation and improve the accuracy of clinical diagnosis and treatment of modern diseases , which is an important path to the preservation and innovative development of TCM.
宋珏娴 , 傅晓燕 , 仝小林 . 现代医学背景下中医诊疗体系的重构 [J]. 中医杂志 , 2018 , 59 ( 1 ): 6 - 9 .
魏佳 , 李灿东 . 中医病名规范化研究现状与对策 [J]. 中华中医药杂志 , 2021 , 36 ( 3 ): 1217 - 1220 .
仝小林 , 何莉莎 , 赵林华 . 论“态靶因果”中医临床辨治方略 [J]. 中医杂志 , 2015 , 56 ( 17 ): 1441 - 1444 .
沈自尹 . 微观辨证和辨证微观化 [J]. 中医杂志 , 1986 ( 2 ): 55 - 57 .
宋美芳 , 陈家旭 , 彭晨习 , 等 . 论中医微观辨证 [J]. 中华中医药杂志 , 2019 , 34 ( 7 ): 2867 - 2869 .
魏军平 , 刘芳 , 周丽波 , 等 . 北京市糖耐量异常和糖尿病危险因素及中医证候流行病学调查 [J]. 北京中医药 , 2010 , 29 ( 10 ): 731 - 737 .
REDDY MA , ZHANG E , NATARAJAN R . Epigenetic mechanisms in diabetic complications and metabolic memory [J]. Diabetologia , 2015 , 58 ( 3 ): 443 - 455 .
仝小林 . 中医肺毒疫辨识 [J]. 中医杂志 , 2003 , 53 ( 12 ): 885 - 887 .
仝小林 , 李修洋 , 赵林华 , 等 . 从“寒湿疫”角度探讨新型冠状病毒肺炎的中医药防治策略 [J]. 中医杂志 , 2020 , 61 ( 6 ): 465 - 470,553 .
郑玉娇 , 苟筱雯 , 逄冰 , 等 . “糖络病”学说及其诊疗要点发微 [J]. 中医杂志 , 2019 , 60 ( 22 ): 1920 - 1923 .
王翼天 , 仝小林 . 分类、分期、分证思想对慢性病中医理论构建的启示 [J]. 中医杂志 , 2017 , 58 ( 24 ): 2091 - 2094 .
仝小林 , 刘文科 , 王佳 , 等 . 糖尿病郁热虚损不同阶段辨治要点及实践应用 [J]. 吉林中医药 , 2012 , 32 ( 5 ): 442 - 444 .
苟筱雯 , 赵林华 , 何莉莎 , 等 . 从态靶辨证谈中医治疗2型糖尿病的用药策略 [J]. 辽宁中医杂志 , 2020 , 47 ( 4 ): 1 - 4 .
仝小林 , 王跃生 , 傅延龄 , 等 . 方药量效关系研究思路探讨 [J]. 中医杂志 , 2010 , 51 ( 11 ): 965 - 967 .
傅延龄 , 宋佳 , 张林 . 经方本原剂量研究的意义 [J]. 北京中医药大学学报 , 2013 , 36 ( 4 ): 231 - 233 .
ZHAO LH , HE LS , LIAN FM , et al . Clinical strategy for optimal traditional Chinese medicine (TCM) herbal dose selection in disease therapeutics: expert consensus on classic TCM herbal formula dose conversion [J]. Am J Chin Med , 2015 , 43 ( 8 ): 1515 - 1524 .
0
浏览量
4
下载量
13
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号